Atlas Trials

Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Clinical trial NCT06362694 · UNKNOWN

Trial details

NCT number
NCT06362694
Sponsor
Saint Petersburg State University, Russia
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic Thyroid Cancer
Start date
2024-03-25
Primary completion
2026-03-25
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.